Avid Bioservices Inc
(CDMO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 10-2024 | 07-2024 | 04-2024 | 01-2024 | 10-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,940 | -5,534 | -140,753 | -17,649 | -11,643 |
| Depreciation Amortization | 7,381 | 3,129 | 12,612 | 9,165 | 6,072 |
| Income taxes - deferred | N/A | N/A | 113,823 | -4,093 | -3,009 |
| Accounts receivable | -1,767 | -4,318 | 1,654 | -240 | 4,919 |
| Accounts payable and accrued liabilities | -9,370 | -451 | 7,133 | 3,140 | 4,344 |
| Other Working Capital | 9,739 | -3,940 | 13,447 | 14,958 | 9,733 |
| Other Operating Activity | 17,271 | 7,434 | 3,036 | 4,414 | -4,408 |
| Operating Cash Flow | $314 | $-3,680 | $10,952 | $9,695 | $6,008 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,758 | -1,311 | -31,805 | -26,112 | -21,624 |
| Investing Cash Flow | $-4,758 | $-1,311 | $-31,805 | $-26,112 | $-21,624 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 17,943 | 7,412 | 7,412 |
| Debt Repayment | -972 | -350 | -618 | -561 | -262 |
| Common Stock Issued | 725 | 616 | 1,396 | 1,382 | 998 |
| Other Financing Activity | 0 | 0 | 1,346 | 0 | 0 |
| Financing Cash Flow | $-247 | $266 | $20,067 | $8,233 | $8,148 |
| Beginning Cash Position | 38,106 | 38,106 | 38,892 | 38,892 | 38,892 |
| End Cash Position | 33,415 | 33,381 | 38,106 | 30,708 | 31,424 |
| Net Cash Flow | $-4,691 | $-4,725 | $-786 | $-8,184 | $-7,468 |
| Free Cash Flow | |||||
| Operating Cash Flow | 314 | -3,680 | 10,952 | 9,695 | 6,008 |
| Capital Expenditure | -4,758 | -1,311 | -31,805 | -26,112 | -21,624 |
| Free Cash Flow | -4,444 | -4,991 | -20,853 | -16,417 | -15,616 |